Perceptive Xontogeny Venture Fund, LP's Net Worth
$112 Million
Who is Perceptive Xontogeny Venture Fund, LP?
Perceptive Xontogeny Venture Fund, LP has an estimated net worth of $112 Million. This is based on reported shares across multiple companies, which include LianBio, Landos Biopharma, Inc., Astria Therapeutics, Inc., and Solid Biosciences Inc..
SEC CIK
Perceptive Xontogeny Venture Fund, LP's CIK is 0001757940
Past Insider Trading and Trends
2021 was Perceptive Xontogeny Venture Fund, LP's most active year for acquiring shares with 24 total transactions. Perceptive Xontogeny Venture Fund, LP's most active month to acquire stocks was the month of January. 2021 was Perceptive Xontogeny Venture Fund, LP's most active year for disposing of shares, totalling 10 transactions. Perceptive Xontogeny Venture Fund, LP's most active month to dispose stocks was the month of January. 2021 saw Perceptive Xontogeny Venture Fund, LP paying a total of $82,158,285.97 for 55,746,189 shares, this is the most they've acquired in one year. In 2021 Perceptive Xontogeny Venture Fund, LP cashed out on 19,928,676 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LianBio (LIAN) Snapshot price: $4.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +36.56% | 1M |
$2.40 | $2,395,776.00 | 3.73M |
Aug 18
| |||
Form 4
| +2.59% | 69K |
$3.13 | $215,970.00 | 2.73M |
May 26
| |||
Form 4
| +6.88% | 171.25K |
$2.58 | $442,363.97 | 2.66M |
May 23 - May 25
| |||
Form 4
| +8.87% | 2.27M |
$15.98 | $36,270,200.00 | 27.86M |
Nov 3
| |||
Form 4
| +249.26% | 38.57M |
$14.59 |
—
| 54.05M |
Nov 1 - Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Landos Biopharma, Inc. (LABP) Snapshot price: $5.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 4
| +3.55% | 250.19K |
$12.84 | $3,212,445.93 | 7.3M |
Feb 5 - Feb 9
| |||
Form 4
| +167.25% | 14.62M |
$16.00 | $20,000,000.00 | 23.36M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Astria Therapeutics, Inc. (ATXS) Snapshot price: $14.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +103.72% | 2.48M |
$12.09 | $29,999,521.50 | 4.87M |
Feb 1
| |||
Form 4
| +44.78% | 740K |
$6.20 | $4,588,000.00 | 2.39M |
Dec 21
| |||
Form 4
| +49.08% | 1.07M |
$6.51 | $6,999,996.51 | 3.26M |
Oct 16
| |||
Form 4
| +698.43% | 908.26K |
$11.01 | $9,999,997.65 | 1.04M |
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Solid Biosciences Inc. (SLDB) Snapshot price: $7.175
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +99.65% | 3.41M |
$5.53 | $18,861,242.89 | 6.83M |
Jan 11
| |||
Form 4
| +290.97% | 2.6M |
$7.05 |
—
| 3.5M |
Dec 2
| |||
| No matching records found | |||||||||